{"log_id": 1890527601264027054, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.008676, "average": 0.948217, "min": 0.56323}, "location": {"width": 801, "top": 167, "height": 28, "left": 195}, "words": "致死的可能。因此,卡培他滨不应与索立夫定及其类似物(如溴夫定)同时给药(见【禁忌)"}, {"probability": {"variance": 0.000415, "average": 0.990743, "min": 0.915483}, "location": {"width": 811, "top": 206, "height": 28, "left": 196}, "words": "在结束索立定及其类似物治疗(如溴夫定)到开始卡培他滨治疗之间必须有至少周的等待"}, {"probability": {"variance": 0, "average": 0.997257, "min": 0.997257}, "location": {"width": 24, "top": 247, "height": 25, "left": 196}, "words": "期"}, {"probability": {"variance": 0.006665, "average": 0.959686, "min": 0.535803}, "location": {"width": 769, "top": 287, "height": 27, "left": 238}, "words": "奥沙利:奥沙利铂与卡培他滨联会用药时(伴有或不伴有贝伐单抗),卡培他滨或其代"}, {"probability": {"variance": 0.004483, "average": 0.972849, "min": 0.699063}, "location": {"width": 412, "top": 326, "height": 26, "left": 195}, "words": "谢物,游离铂或总铂暴露量无临床上著差异"}, {"probability": {"variance": 0.004101, "average": 0.979767, "min": 0.651748}, "location": {"width": 761, "top": 366, "height": 27, "left": 238}, "words": "贝伐单抗:贝伐单抗对卡培他滨或其代谢物的药代动力学参数无量著临床意义的影响"}, {"probability": {"variance": 2e-06, "average": 0.998177, "min": 0.996306}, "location": {"width": 112, "top": 405, "height": 25, "left": 202}, "words": "【药物过量】"}, {"probability": {"variance": 0.00453, "average": 0.974218, "min": 0.601815}, "location": {"width": 773, "top": 444, "height": 26, "left": 235}, "words": "急性药物过量的表现为:恶心、呕吐、腹泻、粘膜炎、胃肠道刺激和出血,以及骨髓抑"}, {"probability": {"variance": 0, "average": 0.996906, "min": 0.996906}, "location": {"width": 25, "top": 481, "height": 26, "left": 196}, "words": "制"}, {"probability": {"variance": 0.012251, "average": 0.95832, "min": 0.398041}, "location": {"width": 764, "top": 521, "height": 27, "left": 234}, "words": "药物过量的医疗处理应包括:常规治疗、支持治疗(旨在纠正临床表现)及预防发症"}, {"probability": {"variance": 0.001841, "average": 0.975797, "min": 0.881849}, "location": {"width": 113, "top": 559, "height": 25, "left": 201}, "words": "【药理毒理】"}, {"probability": {"variance": 8e-06, "average": 0.996607, "min": 0.993283}, "location": {"width": 85, "top": 598, "height": 25, "left": 198}, "words": "药理作用"}, {"probability": {"variance": 0.020174, "average": 0.941715, "min": 0.387245}, "location": {"width": 772, "top": 638, "height": 27, "left": 236}, "words": "正常细胞和肿瘤细胞都能将5-FU代谢为氟-2脱氧尿苷酸单磷酸( (FDUMP)和5氟尿"}, {"probability": {"variance": 0.007869, "average": 0.960378, "min": 0.577925}, "location": {"width": 810, "top": 676, "height": 28, "left": 197}, "words": "三磷酸(FUTP)。这些代谢产物通过二种不同机制引起细胞损伤。首先, Fdump及叶酸协同"}, {"probability": {"variance": 0.02715, "average": 0.928818, "min": 0.35586}, "location": {"width": 813, "top": 716, "height": 29, "left": 194}, "words": "因子N1亚甲基四氢酸与胸苷酸合成酶CTS)结合形成共价结合的三重复合物,这种结合"}, {"probability": {"variance": 0.008404, "average": 0.975882, "min": 0.437399}, "location": {"width": 794, "top": 754, "height": 31, "left": 194}, "words": "抑制2脱氧尿嘧啶核苷酸形成胸核苷酸胸核苷酸是胸腺嘧啶核苷三磷酸必需的前体"}, {"probability": {"variance": 0.002559, "average": 0.981499, "min": 0.710887}, "location": {"width": 814, "top": 794, "height": 29, "left": 195}, "words": "而后者是DNA合成所必需的,因此该化合物的不足能抑制细胞分裂。其次,在RNA合成"}, {"probability": {"variance": 0.004169, "average": 0.979196, "min": 0.616762}, "location": {"width": 813, "top": 834, "height": 30, "left": 194}, "words": "过程中核转录酶可能会在尿苷二磷酸(UTP)的部位错误地编入FUTP。这种代谢错误将会干"}, {"probability": {"variance": 0.027553, "average": 0.919645, "min": 0.420028}, "location": {"width": 324, "top": 874, "height": 25, "left": 194}, "words": "扰RNA的加工处理和蛋自质的成"}, {"probability": {"variance": 2.1e-05, "average": 0.99697, "min": 0.98899}, "location": {"width": 97, "top": 913, "height": 25, "left": 197}, "words": "毒理研究"}, {"probability": {"variance": 0.00305, "average": 0.983675, "min": 0.696202}, "location": {"width": 789, "top": 951, "height": 29, "left": 235}, "words": "目前尚无足够多的研究评价卡培他滨的致癌性卡培他滨在体外不引起细菌(Ames试验"}, {"probability": {"variance": 0.007368, "average": 0.969535, "min": 0.534751}, "location": {"width": 813, "top": 991, "height": 29, "left": 195}, "words": "或哺乳动物细胞(中国仓鼠V79/HPRT基因突变分析)突变。卡培他滨在体外对人体外周血港"}, {"probability": {"variance": 0.001641, "average": 0.984515, "min": 0.813351}, "location": {"width": 813, "top": 1030, "height": 27, "left": 194}, "words": "巴细胞有致断裂作用,而在小鼠骨髓活体内(微核试验)却无致断裂作用。氟尿嘧啶引起细菌"}, {"probability": {"variance": 0.002999, "average": 0.987955, "min": 0.714327}, "location": {"width": 538, "top": 1069, "height": 26, "left": 194}, "words": "和酵母的突变,还在小鼠体内的微核试验中引起染色体异常"}, {"probability": {"variance": 0.004294, "average": 0.97144, "min": 0.702046}, "location": {"width": 774, "top": 1108, "height": 29, "left": 236}, "words": "在小鼠的生育能力和总繁殖表现的研究中,口服卡培他滨760mg/kg天扰乱了发请期并"}, {"probability": {"variance": 0.007053, "average": 0.974003, "min": 0.552204}, "location": {"width": 814, "top": 1146, "height": 31, "left": 195}, "words": "导致生育能力下降。在妊娠小鼠中,此剂量下无胚胎存活。发情期的扰乱是可逆的。该剂量"}, {"probability": {"variance": 3.7e-05, "average": 0.997775, "min": 0.963488}, "location": {"width": 813, "top": 1186, "height": 30, "left": 195}, "words": "在这个试验中引起了雄性的退化改变,包括精母细胞和精子细胞数目的减少。单独的药代动"}, {"probability": {"variance": 0.00987, "average": 0.971002, "min": 0.508713}, "location": {"width": 800, "top": 1227, "height": 27, "left": 196}, "words": "力学研究显示,对应于小鼠该$- DFUR AUC值的剂量大约是患者每日建议剂量的0.7倍"}, {"probability": {"variance": 5e-06, "average": 0.998172, "min": 0.993065}, "location": {"width": 134, "top": 1265, "height": 27, "left": 201}, "words": "【药代动力学】"}, {"probability": {"variance": 0.001988, "average": 0.983271, "min": 0.799097}, "location": {"width": 772, "top": 1305, "height": 28, "left": 237}, "words": "卡培他滨在体外相对无细胞毒性。在体内该药在酶的作用下转化为5-氟尿嘧啶(5-FU)"}, {"probability": {"variance": 6e-06, "average": 0.997528, "min": 0.993394}, "location": {"width": 85, "top": 1343, "height": 26, "left": 194}, "words": "发挥作用"}, {"probability": {"variance": 4e-06, "average": 0.994801, "min": 0.992894}, "location": {"width": 86, "top": 1383, "height": 25, "left": 197}, "words": "生物活化"}, {"probability": {"variance": 0.002408, "average": 0.986546, "min": 0.775954}, "location": {"width": 772, "top": 1423, "height": 28, "left": 237}, "words": "卡培他滨易于从胃肠道吸收。在肝中,一种60KD的羧酸酯酶将卡培他滨大部分水解为"}, {"probability": {"variance": 0.010598, "average": 0.964042, "min": 0.404229}, "location": {"width": 809, "top": 1463, "height": 28, "left": 194}, "words": "5-脱氧-5-氟胞苷(5-DFCR)。接着由存在于大多数组织包括肿瘤组织中的胞苷脱氨酶将5"}, {"probability": {"variance": 0.01093, "average": 0.959216, "min": 0.389821}, "location": {"width": 580, "top": 1503, "height": 27, "left": 200}, "words": "DFCR转化为5-脱氧-5-氟尿苷(5-DFUR)。然后胸苷磷酸化酶(d"}, {"probability": {"variance": 0.002463, "average": 0.97643, "min": 0.845804}, "location": {"width": 154, "top": 1507, "height": 23, "left": 854}, "words": "将5DFUR水解"}], "language": 3}